Overview Efficacy Study in Patients With Acne Vulgaris. Status: Completed Trial end date: 2017-03-21 Target enrollment: Participant gender: Summary Safety and efficacy study in patients with acne vulgaris Phase: Phase 2 Details Lead Sponsor: Taro Pharmaceuticals USA